Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identifying distinct classes of bladder carcinoma using microarrays.

Lars Dyrskjøt1, Thomas Thykjaer, Mogens Kruhøffer

  • 1Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark.

Nature Genetics
|December 7, 2002
PubMed
Summary

Researchers identified molecular subtypes of bladder cancer using gene expression analysis. A 32-gene classifier accurately stages tumors and predicts recurrence, offering new therapeutic targets for bladder carcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aspirin or non-steroidal anti-inflammatory drug initiation and subsequent bladder cancer evaluation.

Journal of internal medicine·2026
Same author

Lipoprotein(a), interleukin-6 and cardiovascular risk in a primary prevention setting.

Atherosclerosis·2026
Same author

Immune profiling of T cells: A comparative analysis of single-cell TCR sequencing using 10X Genomics and Parse Biosciences platforms.

Biochemistry and biophysics reports·2026
Same author

Plasma proteomic signature of the human menstrual cycle.

Nature medicine·2026
Same author

Fibrotic disease co-occurrence and associated risk of subsequent organ failure: a nationwide matched cohort study.

Rheumatology (Oxford, England)·2026
Same author

Cell-Free DNA-Derived Immune Cell Ratios Uncover Cancer-Associated Systemic Changes.

Cancer research communications·2026

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Bladder cancer is a common malignancy with frequent recurrences.
  • Current staging and molecular markers are insufficient for defining clinically relevant bladder cancer subsets.
  • Identifying new biomarkers is crucial for predicting disease progression and guiding therapy.

Purpose of the Study:

  • To identify clinically relevant subclasses of bladder carcinoma using gene expression profiling.
  • To develop a molecular classifier for accurate tumor staging and prediction of recurrence.
  • To uncover novel therapeutic targets based on distinct gene expression profiles.

Main Methods:

  • Expression microarray analysis of 40 well-characterized bladder tumors.
  • Hierarchical cluster analysis to identify tumor stages (Ta, T1, T2-4).

Related Experiment Videos

  • Development of a 32-gene molecular classifier using cross-validation and validated on an independent set of 68 tumors.
  • Supervised learning classification to differentiate recurring from non-recurring Ta tumors.

    • Main Results:

    • Hierarchical clustering identified three major stages (Ta, T1, T2-4), with Ta tumors further subclassified.
    • The 32-gene classifier accurately correlated with pathological staging in an independent test set.
    • The classifier provided significant predictive information on disease progression in Ta tumors beyond conventional staging (P < 0.005).
    • Supervised learning correctly classified 75% of recurring versus non-recurring Ta tumors (P < 0.006).

    Conclusions:

    • Gene expression profiling can delineate clinically relevant subclasses of bladder cancer.
    • A 32-gene molecular classifier offers improved prediction of tumor stage and recurrence.
    • Identified gene expression profiles provide insights into tumor biology and potential therapeutic targets for bladder carcinoma.